All In Biotech

Drug Trial Radar · NCT02914509

Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHT

A Prospective, Multicenter, Randomized, Parallel-Arm, Double Masked, Vehicle Controlled Phase 3A Study Evaluating the Safety and Efficacy of OTX-TP in the Treatment of Subjects With Open-Angle Glaucoma or Ocular Hypertension

Last checked: Nov 19, 2026Latest source record: Oct 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 565 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

565

Actual

Start

Nov 7, 2016

Primary completion

Mar 30, 2019

Study completion Mar 30, 2019

Sponsor

Lead sponsor
Ocular Therapeutix, Inc.Industry
Sponsor type
Industry
First posted
Sep 26, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of the study is to evaluate evaluate the safety and IOP lowering efficacy of OTX-TP, a sustained release travoprost drug product, placed in the canaliculus of the eyelid in the treatment of subjects with open-angle glaucoma or ocular hypertension

Conditions

  • Open Angle Glaucoma
  • Ocular Hypertension

Interventions

  • TravoprostDrug

  • Placebo VehicleOther

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean IOPTime frame: Mean IOP at 8AM, 10AM, and 4PM at the 2 Week Visit
  2. Mean IOPTime frame: Mean IOP at 8AM, 10AM, and 4PM at the 6 Week Visit
  3. Mean IOPTime frame: Mean IOP at 8AM, 10AM, and 4PM at the 12 Week Visit

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Site not named

    Artesia, California

  • Site not named

    Colorado Springs, Colorado

  • Site not named

    Lakeland, Florida

  • Site not named

    Morrow, Georgia

  • Site not named

    Shawnee Mission, Kansas

  • Site not named

    Des Peres, Missouri

  • Site not named

    Rochester, New York

  • Site not named

    Raleigh, North Carolina

  • Site not named

    Cincinnati, Ohio

  • Site not named

    Austin, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.